Young L. Kim
Purdue University
244 Papers
1.2K Citations
Young L. Kim is an academic researcher from Purdue University. The author has contributed to research in topics: Scattering & Light scattering. The author has an hindex of 35, co-authored 222 publications. Previous affiliations of Young L. Kim include Northwestern University & Gwangju Institute of Science and Technology.
Chat about Author
Papers
Graphene-on-silver substrates for sensitive surface plasmon resonance imaging biosensors
TL;DR: Results of the numerical study show that a silver substrate with a few graphene layers can significantly increase the imaging sensitivity, compared to the conventional gold-film-based SPR imaging biosensor.
Simultaneous measurement of angular and spectral properties of light scattering for characterization of tissue microarchitecture and its alteration in early precancer
Young L. Kim,Yang Liu,Ramesh K. Wali,Hemant K. Roy,Michael J. Goldberg,Alexey K. Kromin,Kun Chen,Vadim Backman +7 more
TL;DR: A novel instrument to measure the spectral, angular, azimuthal, and polarization dependence of light backscattered by living biological tissues is presented, thus providing the most comprehensive description of the light scattering to obtain unique quantitative information about the microarchitecture of living cells and tissues.
194
Edible unclonable functions
Jung Woo Leem,Min Seok Kim,Seung Ho Choi,Seong-Ryul Kim,Seong-Wan Kim,Young Min Song,Robert J. Young,Young L. Kim +7 more
TL;DR: Random patterns formed by fluorescent silk microparticles with various excitation and emission pairs are used as an edible physical unclonable function that can directly be attached onto the surface of medicines.
Effect of Nb Doping on Chemical Sensing Performance of Two-Dimensional Layered MoSe2.
Sun Young Choi,Yonghun Kim,Hee-Suk Chung,Ah Ra Kim,Jung-Dae Kwon,Jucheol Park,Young L. Kim,Se-Hun Kwon,Myung Gwan Hahm,Byung Jin Cho +9 more
TL;DR: Nb doping of two-dimensional (2D) MoSe2 layered nanomaterials is a promising approach to improve their gas sensing performance and could be precisely controlled by varying the number of Nb2O5 deposition cycles in the plasma enhanced atomic layer deposition process.
163
Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial
Lihua E. Budde,Joo Y. Song,Young L. Kim,Suzette Blanchard,Jamie Wagner,Anthony S. Stein,Lihong Weng,Marissa Del Real,Rochelle Hernandez,Emanuela Marcucci,Jennifer K Shepphird,Xiuli Wang,Brent L. Wood,Guido Marcucci,Christine E. Brown,Stephen J. Forman +15 more
TL;DR: The primary objective is to test the safety and activity of escalating doses of CD123CAR T cells for patients with relapsed or refractory AML and BPDCN, and all toxicities were reversible and manageable.
152